Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$398M |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$286M |
| 4 |
UnitedHealth
UNH
|
+$267M |
| 5 |
Veralto
VLTO
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$730M |
| 2 |
Meta Platforms (Facebook)
META
|
+$674M |
| 3 |
Costco
COST
|
+$635M |
| 4 |
Amazon
AMZN
|
+$528M |
| 5 |
Expedia Group
EXPE
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $314K | ﹤0.01% |
11,530
+922
| +9% | +$21.7K |
|
1427
Gibraltar Industries
ROCK
$1.34B
| $311K | ﹤0.01% |
4,005
+46
| +1% | +$3.14K |
|
|
NNDM
1428
Nano Dimension
NNDM
$309M
| $311K | ﹤0.01% |
135,735
+38,241
| +39% | +$96.2K |
|
|
MRSN
1429
DELISTED
Mersana Therapeutics
MRSN
| $309K | ﹤0.01% |
+3,822
| New | +$154K |
|
1430
Simmons First National
SFNC
$3.35B
| $308K | ﹤0.01% |
16,197
| – | – |
|
1431
LiveRamp
RAMP
$2.29B
| $307K | ﹤0.01% |
8,690
+85
| +1% | +$2.73K |
|
1432
New York Times
NYT
$11.6B
| $303K | ﹤0.01% |
6,374
-2,640
| -29% | -$116K |
|
1433
Dorman Products
DORM
$4.01B
| $300K | ﹤0.01% |
3,734
-47
| -1% | -$3.51K |
|
1434
First Financial Bancorp
FFBC
$3.55B
| $299K | ﹤0.01% |
12,910
+738
| +6% | +$15.3K |
|
1435
MYR Group
MYRG
$5.9B
| $299K | ﹤0.01% |
2,183
+65
| +3% | +$8.37K |
|
1436
Bloomin' Brands
BLMN
$680M
| $298K | ﹤0.01% |
11,199
| – | – |
|
1437
Bankunited
BKU
$3.38B
| $298K | ﹤0.01% |
9,706
+300
| +3% | +$7.78K |
|
1438
Myriad Genetics
MYGN
$530M
| $297K | ﹤0.01% |
16,428
+5,985
| +57% | +$104K |
|
1439
Jack in the Box
JACK
$278M
| $297K | ﹤0.01% |
3,711
+444
| +14% | +$31.4K |
|
|
CVSA
1440
Covista Inc
CVSA
$3.94B
| $295K | ﹤0.01% |
5,195
-133
| -2% | -$7.09K |
|
1441
StoneCo
STNE
$2.62B
| $294K | ﹤0.01% |
17,649
+6,941
| +65% | +$91.2K |
|
1442
Northwest Bancshares
NWBI
$2.25B
| $294K | ﹤0.01% |
23,767
-2,883
| -11% | -$32.1K |
|
1443
Kennametal
KMT
$2.68B
| $292K | ﹤0.01% |
11,883
+1,645
| +16% | +$39.6K |
|
1444
Cal-Maine
CALM
$4.28B
| $292K | ﹤0.01% |
5,361
-1,184
| -18% | -$58.5K |
|
1445
Amphastar Pharmaceuticals
AMPH
$825M
| $289K | ﹤0.01% |
5,079
+86
| +2% | +$4.52K |
|
1446
Viavi Solutions
VIAV
$9.75B
| $288K | ﹤0.01% |
28,654
| – | – |
|
1447
PROG Holdings
PRG
$1.75B
| $287K | ﹤0.01% |
9,755
+3,881
| +66% | +$114K |
|
|
ZEUS
1448
DELISTED
Olympic Steel
ZEUS
| $287K | ﹤0.01% |
4,599
| – | – |
|
1449
RadNet
RDNT
$4.84B
| $286K | ﹤0.01% |
7,944
+32
| +0.4% | +$1.01K |
|
1450
Vodafone
VOD
$34.9B
| $285K | ﹤0.01% |
31,980
+12,404
| +63% | +$113K |
|
Similar funds
Amundi's Q4 2023 Portfolio in Review
As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
- Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
- Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
- Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
- Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
- Amundi opened 107 new positions and closed 120 in Q4 2023.
- Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.
Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.